|
HY-135932-50mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P700717-100ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-P700717-20ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-P700717-50ug
|
MedChemexpress LLC
|
MPZL2, Human (HEK293, hFc)
|
|
|
|
|
HY-132301-10mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-100mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-25mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-5mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-50mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-1mL
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-140521-100mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140521-50mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-100mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-25mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-250mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-50mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140087-100mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-25mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-50mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140867-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-250mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140562-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-Boc [CAS 2093153-07-0]
|
|
Cancer-programmed cell death
|
|
|
HY-140562-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-Boc [CAS 2093153-07-0]
|
|
Cancer-programmed cell death
|
|
|
HY-140559-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-NHS ester [CAS 2093153-85-4]
|
|
Cancer-programmed cell death
|
|
